CD8A and melanoma: In mouse melanoma models, NPs effectively suppressed tumor progression and improved anti‐tumor immunity by recruiting DC cells, CD8+ T cells, and NK cells, converting the “immune‐cold” tumor to “immune‐hot” tumor.